[Hyperbaric oxygen therapy in sudden deafness].
Based on two independent studies, an attempt is made in this paper to demonstrate the effect of hyperbaric oxygen therapy used as a supportive measure to accompany standard treatment in recent acute loss of hearing and in acute loss of hearing where preoperative treatment has proved unsatisfactory. Whereas hyperbaric oxygen therapy is superior to the standard treatment alone as far as the cochlear perception dysacousis and tinnitus in recent acute loss of hearing are concerned, these results could not be reproduced in existing, preoperatively treated acute loss of hearing. As such, hyperbaric oxygen therapy under the strict supervision of a specialist physician has proved an effective supportive measure in the treatment of recent acute loss of hearing.
D001301:Audiometry, Pure-Tone; D001309:Auditory Threshold; D003131:Combined Modality Therapy; D005260:Female; D003639:Hearing Loss, Sudden / Q000628:therapy*; D006801:Humans; D006931:Hyperbaric Oxygenation / Q000295:instrumentation; D007759:Labyrinth Diseases / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009257:Nafronyl / Q000627:therapeutic use; D014012:Tinnitus / Q000628:therapy; D014722:Vestibule, Labyrinth; D014803:Vitamin B Complex / Q000627:therapeutic use
D014803:Vitamin B Complex; D009257:Nafronyl
Zur hyperbaren Sauerstofftherapie beim Hörsturz.